Warfarin

ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
Fierce Pharma
Pfizer
Bristol-Myers Squibb
Eliquis
Warfarin
bloodthinners
Europe
ESC
European Society of Cardiology
Flag link:
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
Fierce Pharma
Pfizer
Bristol-Myers Squibb
JNJ
Eliquis
Xarelto
Warfarin
bloodthinners
Flag link:
How Bristol-Myers and Pfizer are using real-world data to unseat warfarin
How Bristol-Myers and Pfizer are using real-world data to unseat warfarin
Biopharma Dive
Bristol-Myers Squibb
Pfizer
Warfarin
real world evidence
RWE
bloodthinners
Eliquis
Flag link:
Bristol-Myers calls on real-world evidence to unseat warfarin
Bristol-Myers calls on real-world evidence to unseat warfarin
Biopharma Dive
Bristol-Myers Squibb
Warfarin
Eliquis
Pfizer
bloodthinners
Flag link:
Bristol-Myers and Pfizer's Eliquis outperforms rivals versus warfarin
Bristol-Myers and Pfizer's Eliquis outperforms rivals versus warfarin
BioPharma Dive
Bristol-Myers Squibb
Pfizer
Eliquis
bloodthinners
Warfarin
Flag link:
How can Pradaxa, Xarelto and Eliquis finally unseat warfarin? Safety data, analyst says
How can Pradaxa, Xarelto and Eliquis finally unseat warfarin? Safety data, analyst says
Fierce Pharma
Pradaxa
Xarelto
Eliquis
bloodthinners
Warfarin
drug safety
JNJ
Boehringer Ingelheim
Pfizer
Bristol-Myers Squibb
Flag link:
Warfarin's Loss is Johnson & Johnson's Gain
Warfarin's Loss is Johnson & Johnson's Gain
Motley Fool
JNJ
bloodthinners
Warfarin
Pradaxa
Xarelto
Boehringer Ingelheim
Flag link:
Pfizer, Bristol-Myers announce results of subanalysis of Phase 3 ARISTOTLE trial
Pfizer, Bristol-Myers announce results of subanalysis of Phase 3 ARISTOTLE trial
Yahoo/Fly on the Wall
Pfizer
Bristol-Myers Squibb
Eliquis
Warfarin
bloodthinners
Flag link:
New Anticoagulant From Daiichi Sankyo Works Well In AF Patients
New Anticoagulant From Daiichi Sankyo Works Well In AF Patients
Forbes
Daiichi Sankyo
edoxaban
bloodthinners
Warfarin
atrial fibrillation
Flag link:
Daiichi Sankyo’s New Blood Thinner Matched Warfarin in Study
Daiichi Sankyo’s New Blood Thinner Matched Warfarin in Study
Bloomberg
bloodthinners
Daiichi Sankyo
Warfarin
edoxaban
Flag link:
Pfizer’s Eliquis Stops Blood Clots as Well as Standard
Pfizer’s Eliquis Stops Blood Clots as Well as Standard
Bloomberg
Pfizer
Eliquis
blood clots
Bristol-Myers Squibb
Warfarin
Flag link:
New clot preventer works as well as warfarin with less bleeding
New clot preventer works as well as warfarin with less bleeding
Reuters
anti-clotting
Eliquis
Warfarin
Pfizer
Bristol-Myers Squibb
Flag link:
Top heart doctors fret over new blood thinners
Top heart doctors fret over new blood thinners
Reuters
bloodthinners
Warfarin
Pradaxa
Boehringer Ingelheim
Xarelto
JNJ
Bayer
Flag link:
Study: Pradaxa use results in higher per-patient costs
Study: Pradaxa use results in higher per-patient costs
Fierce Pharma
Boehringer Ingelheim
Pradaxa
bloodthinners
Warfarin
Flag link:
ELIQUIS® (apixaban) was Superior to Warfarin for the Reduction of Stroke or Systemic Embolism with Significantly Less Major Bleeding in Patients with Atrial Fibrillation in Phase 3 ARISTOTLE Trial
ELIQUIS® (apixaban) was Superior to Warfarin for the Reduction of Stroke or Systemic Embolism with Significantly Less Major Bleeding in Patients with Atrial Fibrillation in Phase 3 ARISTOTLE Trial
Yahoo/BusinessWire
Eliquis
Apixaban
Warfarin
atrial fibrillation
stroke
Bristol-Myers Squibb
Pfizer
ARISTOTLE trial
Flag link:
Pfizer, Bristol-Myers Blood Thinner Tops Warfarin in Stroke
Pfizer, Bristol-Myers Blood Thinner Tops Warfarin in Stroke
Bloomberg
Warfarin
Pfizer
blood thinners
Bristol-Myers Squibb
Apixaban
Flag link:
Bayer Blood Thinner Xarelto Matches Warfarin in Irregular-Heartbeat Trial
Bayer Blood Thinner Xarelto Matches Warfarin in Irregular-Heartbeat Trial
Bloomberg
Bayer
blood thinners
Xarelto
Warfarin
Flag link:
Boehringer Wins FDA Approval for First Warfarin Rival
Boehringer Wins FDA Approval for First Warfarin Rival
Bloomberg
FDA
Boehringer Ingelheim
Warfarin
Bayer
Pradaxa
blood thinners
Flag link:
Pfizer, Bayer, Boehringer Bid to Replace Warfarin in Stroke-Drug Market
Pfizer, Bayer, Boehringer Bid to Replace Warfarin in Stroke-Drug Market
Bloomberg
Pfizer
Bayer
Boehringer Ingelheim
Warfarin
Pradaxa
blood thinners
Flag link:
Bristol-Myers, Pfizer gain on blood-thinner test results
Bristol-Myers, Pfizer gain on blood-thinner test results
MarketWatch
Bristol-Myers Squibb
Pfizer
Apixaban
atrial fibrillation
Warfarin
blood thinners
Flag link:

Pages